Cargando…
A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay
Polo-like kinase 1 (PLK1), one of the key regulators of mitosis, is a target for cancer therapy due to its abnormally high activity in several tumors. Plk1 is highly conserved and shares a nearly identical 3-D structure between zebrafish and humans. The initial 10 mitoses of zebrafish embryonic clea...
Autores principales: | Lu, Jing, Xin, Shengchang, Meng, Huan, Veldman, Matt, Schoenfeld, David, Che, Chao, Yan, Ruibin, Zhong, Hanbing, Li, Song, Lin, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637257/ https://www.ncbi.nlm.nih.gov/pubmed/23658603 http://dx.doi.org/10.1371/journal.pone.0053317 |
Ejemplares similares
-
Kaempferol Identified by Zebrafish Assay and Fine Fractionations Strategy from Dysosma versipellis Inhibits Angiogenesis through VEGF and FGF Pathways
por: Liang, Fang, et al.
Publicado: (2015) -
Disruption of LRRK2 Does Not Cause Specific Loss of Dopaminergic Neurons in Zebrafish
por: Ren, Guiqi, et al.
Publicado: (2011) -
Identifying Tumor Cell Growth Inhibitors by Combinatorial Chemistry and Zebrafish Assays
por: Xiang, Jing, et al.
Publicado: (2009) -
Nom1 Mediates Pancreas Development by Regulating Ribosome Biogenesis in Zebrafish
por: Qin, Wei, et al.
Publicado: (2014) -
The Bruton’s Tyrosine Kinase Inhibitor Ibrutinib Impairs the Vascular Development of Zebrafish Larvae
por: Wang, Kun, et al.
Publicado: (2021)